symbol,name,description,country,year,period,documentUrl,income,expenses,postedName,date,clientId,registrantId,senateId,houseRegistrantId
RVNC,REVANCE THERAPEUTICS INC.,Biotechnology,US,2022,Q2,https://lda.senate.gov/filings/public/filing/e6ef0146-024c-44c9-bdf8-d0b5f40295d2/print/,20000,,,,208456,46038,46038-208456,34381
RVNC,REVANCE THERAPEUTICS INC.,Biotechnology,US,2022,Q3,https://lda.senate.gov/filings/public/filing/0bd7bf34-29ca-4adc-a270-272c2dd091c8/print/,20000,,,,208456,46038,46038-208456,34381
RVNC,REVANCE THERAPEUTICS INC.,Biotechnology,US,2022,Q4,https://lda.senate.gov/filings/public/filing/f54e6968-a9a4-48cd-8999-0c080bb787a4/print/,20000,,,,208456,46038,46038-208456,34381
